Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease.
Richard A BrownGregory Y H LipChetan VarmaEduard ShantsilaPublished in: European journal of clinical investigation (2018)
Monocyte-platelet aggregates with Mon2 are increased in patients with diffuse CAD and therefore could represent an important contributor to accelerated coronary atherosclerotic progression by a mechanism involving microvascular endothelial dysfunction.
Keyphrases
- coronary artery disease
- endothelial cells
- dendritic cells
- percutaneous coronary intervention
- cardiovascular events
- coronary artery bypass grafting
- peripheral blood
- induced pluripotent stem cells
- low grade
- aortic stenosis
- coronary artery
- pluripotent stem cells
- immune response
- cardiovascular disease
- left ventricular